05:13:57 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Aphria Inc
Symbol APH
Shares Issued 124,384,220
Close 2017-03-08 C$ 6.29
Market Cap C$ 782,376,744
Recent Sedar Documents

Aphria promises to never use chemical pesticides

2017-03-08 17:26 ET - News Release

Mr. Vic Neufeld reports

APHRIA AFFIRMS ITS COMMITMENT TO PRODUCING SAFE MEDICAL CANNABIS 100% FREE OF CHEMICAL PESTICIDES

Aphria Inc., in light of recent media coverage, today provides the following statement with respect to its commitment to providing pharmaceutical-grade cannabis that is free of chemical pesticides.

Vic Neufeld, chief executive officer of Aphria, said:

"Aphria has always held itself to the highest standards when it comes to the cultivation and production of medical cannabis. As part of this, we made a strategic investment in a state-of-the-art greenhouse in Leamington, Ont., which enables us to produce medical cannabis that meets our exacting standards of quality, consistency and safety.

"Aphria is committed to product integrity through every step of the growing process. We make our own fertilizer, which significantly reduces the risk of unwanted chemicals that can be found in 'premixed' fertilizers. Additionally, we do not use chemical pesticides in the production of medical cannabis; we only use biological controls in the Leamington greenhouse. To be clear, Aphria has never supported the use of myclobutanil.

"Since Aphria was founded, we have enforced a strict quality management program that continuously tests for pesticides, including myclobutanil. We closely monitor all suppliers to ensure that any products used meet or exceed the minimum standards set to comply with Health Canada's regulations. As we noted in December, we support the use of independent evaluations and testing of medical cannabis as a necessary measure to protect the safety of Canadians.

"In all, Aphria has adopted pharmaceutical-grade quality assurance and quality control processes, many of which are over and above what is required by Health Canada. We recognize that patients rely on a safe and high-quality product to meet their medical needs and it is critically important that all products sold through the ACMPR adhere to the strict guidelines established by Health Canada to ensure that their needs are met.

"Aphria management has over 35 years of experience in agriculture and 20 years in the pharmaceutical space, we don't need to rely on chemicals because we know how to grow naturally."

About Aphria Inc.

Aphria, one of Canada's lowest cost producers, grows, supplies and sells medical cannabis. The company is the first publicly licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.